Srs Capital Advisors, Inc. Amgen Inc Transaction History

Srs Capital Advisors, Inc.

$1.07 Billion
Q3 2024

A detailed history of Srs Capital Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 712 shares of AMGN stock, worth $209,705. This represents 0.02% of its overall portfolio holdings.

Number of Shares

712

Previous 698 2.01%

Holding current value

$209,705

Previous $218,000 5.05%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$309.38 - $337.38 $4,331 - $4,723	14 Added 2.01%	712 $229,000
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $155,548 - $189,031	592 Added 558.49%	698 $218,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $268 - $324	1 Added 0.95%	106 $30,000
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $255 - $288	-1 Reduced 0.94%	105 $30,000
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $2,405 - $2,986	11 Added 11.58%	106 $28,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $2,142 - $2,533	-10 Reduced 9.52%	95 $21,000
Q1 2023 May 16, 2023	BUY	$225.79 - $275.2 $5,418 - $6,604	24 Added 29.63%	105 $25,000
Q4 2022 Feb 24, 2023	SELL	$229.03 - $291.01 $458 - $582	-2 Reduced 2.41%	81 $21,000
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $998,398 - $1.13 Million	-4,448 Reduced 98.17%	83 $19,000
Q2 2022 Aug 22, 2022	BUY	$230.71 - $256.74 $922 - $1,026	4 Added 0.09%	4,531 $1.1 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $1,973 - $2,183	9 Added 0.2%	4,527 $1.1 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $47,930 - $54,851	-241 Reduced 5.06%	4,518 $1.02 Million
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $25,260 - $29,595	119 Added 2.56%	4,759 $1.01 Million
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $3,737 - $4,146	16 Added 0.35%	4,640 $1.13 Million
Q4 2020 Feb 03, 2021	SELL	$216.38 - $257.67 $25,965 - $30,920	-120 Reduced 2.53%	4,624 $1.06 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $220,805 - $245,553	-941 Reduced 16.55%	4,744 $1.21 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $42,133 - $51,703	-213 Reduced 3.61%	5,685 $1.34 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $6,013 - $7,976	-33 Reduced 0.56%	5,898 $1.2 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $906,694 - $1.17 Million	4,792 Added 420.72%	5,931 $1.43 Million
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $522 - $625	3 Added 0.26%	1,139 $220,000
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $173,201 - $203,030	-1,039 Reduced 47.77%	1,136 $209,000
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $71,181 - $83,091	399 Added 22.47%	2,175 $423,000
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $113,953 - $128,467	-615 Reduced 25.72%	1,776 $368,000
Q2 2018 Aug 21, 2018	BUY	$166.05 - $186.51 $69,741 - $78,334	420 Added 21.31%	2,391 $441,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $13,215 - $15,444	-78 Reduced 3.81%	1,971 $336,000
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $9,789 - $10,938	58 Added 2.91%	2,049 $356,000
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $333,074 - $380,281	1,991	1,991 $371,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Account

Srs Capital Advisors, Inc. Amgen Inc Transaction History